Xiao-He Luo (Xiaohe Luo)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Reactive Oxygen Species

Liver Metastases

Top Venues

Journal of materials chemistry. B

Oxidative medicine and cellular longevity

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Dong Mo, Wei Cui, Linxin Chen, Juanjuan Meng, Yuting Sun, Kaiyong Cai, Jixi Huang, Jianrong Zhang, Kui Wang, Xiao-He Luo
Activation of the PPARγ/NF-κB pathway by A-MPDA@Fe 3 O 4 @PVP via scavenging reactive oxygen species to alleviate hepatic ischemia-reperfusion injury. Journal of materials chemistry. B 12 (23) (2024)
Yao Wu, Min Yang, Shao-Bo Wu, Pei-Qi Luo, Cheng Zhang, Chang-Shun Ruan, Wei Cui, Qiu-Rong Zhao, Lin-Xin Chen, Juan-Juan Meng, Qiang Song, Wen-Jin Zhang, Qin-Qin Pei, Fang Li, Ting Zeng, Hong-Xin Du, Li-Xin Xu, Weizhen Zhang, Xian-Xiang Zhang, Xiao-He Luo
Zinc finger BED-type containing 3 promotes hepatic steatosis by interacting with polypyrimidine tract-binding protein 1. Diabetologia (2024)
Dong Mo, Wei Cui, Linxin Chen, Juanjuan Meng, Yuting Sun, Kaiyong Cai, Jixi Huang, Jianrong Zhang, Kui Wang, Xiao-He Luo
Activation of the PPARγ/NF-κB pathway by A-MPDA@Fe 3 O 4 @PVP via scavenging reactive oxygen species to alleviate hepatic ischemia-reperfusion injury. Journal of materials chemistry. B (2024)
Qiang Song, Wenjin Zhang, Dan Shi, Zhiliang Zhang, Qiurong Zhao, Mengyuan Wang, Man Huang, Juanjuan Meng, Wei Cui, Xiao-He Luo
Overexpression of cannabinoid receptor 2 is associated with human breast cancer proliferation, apoptosis, chemosensitivity and prognosis via the PI3K/Akt/mTOR signaling pathway. Cancer medicine (2023)
Feng Zhang, Qingqing Liu, Kumar Ganesan, Zeng Kewu, Jiangang Shen, Fang Gang, Xiao-He Luo, Jianping Chen
The Antitriple Negative Breast cancer Efficacy of Spatholobus suberectus Dunn on ROS-Induced Noncanonical Inflammasome Pyroptotic Pathway. Oxidative medicine and cellular longevity 2021 (2021)